Skip to content
Clinical Trials – home
CroatiaBack to Croatia

Clinical trials in Virovitica – page 2

23 clinical trials in Virovitica, Croatia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CroatiaOur site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)
Virovitica at a glance
23
clinical trials
  • Not yet recruiting0
  • Research sites0
Type of trial
Recruitment status
Quick filters

23 trials in Virovitica

Open in trial search

Study on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Roflumilast
  • Sponsor:Chiesi Farmaceutici S.p.A.

Study on the Effectiveness and Safety of CHF 5993 Compared to CHF 1535 for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Beclometasone Dipropionate Anhydrous
  • Sponsor:Chiesi Farmaceutici S.p.A.

Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB

Asthma

Not recruiting

Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma Not Well Controlled

Registered drug
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB

Asthma

Not recruiting

Study on Long-Term Safety of Depemokimab for Adults and Adolescents with Severe Eosinophilic Asthma

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited

Asthma

Not recruiting

Study on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma

Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:Areteia Therapeutics Inc.

Asthma

Not recruiting

Study on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Patients with Asthma

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:Teva Branded Pharmaceutical Products R&D LLC

Study on the Safety and Effectiveness of Betula Pollen Extract for Children and Adolescents Aged 5-17 with Birch Pollen Allergies and Possible Asthma

Registered drug
Countries:AustriaAustria
  • Participants:0–17 years
  • Substances:Betula Pollen Extract
  • Sponsor:Stallergenes

Asthma

Not recruiting

Study on Tezepelumab for Children Aged 5 to 11 with Severe Asthma

Registered drug
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Tezepelumab
  • Sponsor:AstraZeneca AB

Asthma+1

Not recruiting

Study on the Effects and Safety of Dupilumab for Children Aged 2 to Under 6 with Uncontrolled Asthma or Severe Asthmatic Wheeze

Registered drug
Countries:CzechiaCzechia
  • Participants:0–17 years
  • Substances:Budesonide
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Other cities in Croatia

The busiest research cities in the country

All 26 cities in Croatia

Clinical research in Virovitica

What the registry says about research in the country

01 Gastroenterology Research

Innovative clinical trials focusing on inflammatory bowel conditions, specifically Ulcerative Colitis and Crohn's Disease. These studies aim to evaluate new therapeutic approaches for patients with moderate to severe symptoms.

  • Novel therapy evaluation for UC treatment
  • Advanced treatments for Crohn's Disease
  • Inflammatory bowel disease management

Research includes investigation of targeted therapies and their effectiveness in achieving clinical remission and improving endoscopic response in patients with inflammatory bowel conditions.

02 Inflammatory Disease Studies

Current research initiatives examine the potential of targeted therapeutic agents in managing chronic inflammatory conditions of the digestive system. These trials focus on developing more effective treatment options for patients with moderate to severe disease activity.

  • Inflammatory response modulation
  • Disease activity assessment
  • Treatment response evaluation

The studies aim to advance our understanding of treatment efficacy and establish new therapeutic approaches for inflammatory bowel conditions.

03 Clinical Therapeutics

Ongoing investigations of novel pharmaceutical compounds for treating gastrointestinal disorders. These studies evaluate both standalone treatments and combination therapies to optimize patient outcomes.

  • Drug efficacy assessment
  • Treatment response monitoring
  • Therapeutic combinations

Research focuses on determining optimal treatment approaches and evaluating clinical endpoints in inflammatory bowel disease management.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.